Drug profile · INN
lodoxamide tromethamine
ALOMIDE
lodoxamide tromethamine (ALOMIDE) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — lodoxamide tromethamine
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
lodoxamide tromethamine (ALOMIDE) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
INN lodoxamide tromethamine
Brand ALOMIDE
Mechanism Unknown
Route OPHTHALMIC
Formulation SOLUTION/DROPS
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is lodoxamide tromethamine?
lodoxamide tromethamine (ALOMIDE) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for lodoxamide tromethamine?
ALOMIDE is a marketed brand name for lodoxamide tromethamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lodoxamide tromethamine?
lodoxamide tromethamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.